Literature DB >> 18093242

Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.

A Patsatsi1, T-A Vyzantiadis, D Devliotou-Panagiotidou, F Chrysomallis, D Sotiriadis.   

Abstract

Bullous pemphigoid (BP) is an acquired bullous disease with an increasing prevalence among elderly people worldwide, including in Greece. Blister formation in most patients with BP is caused by autoantibodies against structural components of the basement membrane zone of the skin, predominantly BP180NC16a and BP230 antigens on the hemidesmosome adhesion complex. Routine diagnostic methods such as histological examination and direct and indirect immunofluorescence are combined to determine diagnosis. In this study, an ELISA was used to measure levels of both anti-BP180NC16A and anti-BP230 autoantibodies in the blister fluid of 13 patients with newly diagnosed BP, before starting treatment. The aim of the study was to evaluate this method as a diagnostic tool in BP. Our results indicate that blister-fluid examination by ELISA can be a useful tool to diagnose bullous pemphigoid, especially in elderly patients who refuse biopsy or have poor venous access.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093242     DOI: 10.1111/j.1365-2230.2007.02622.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study.

Authors:  Alvise Sernicola; Irene Russo; Andrea Saponeri; Mauro Alaibac
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

2.  Detection of Anti-basement Membrane Zone Antibodies in the Blister Fluid in Subepidermal Autoimmune Bullous Diseases.

Authors:  Ravindran Surya; Bobbili Tejasvi; Shrutakirthi D Shenoi; Sathish Pai; Chythra Rao; Raghavendra Rao
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.